Veinotte, L., Gebremeskel, S., & Johnston, B. (2016). CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control. Oncoimmunology.
Chicago-stil citatVeinotte, Linnea, Simon Gebremeskel, och Brent Johnston. "CXCL16-positive Dendritic Cells Enhance Invariant Natural Killer T Cell-dependent IFNγ Production and Tumor Control." Oncoimmunology 2016.
MLA-referensVeinotte, Linnea, Simon Gebremeskel, och Brent Johnston. "CXCL16-positive Dendritic Cells Enhance Invariant Natural Killer T Cell-dependent IFNγ Production and Tumor Control." Oncoimmunology 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.